News
10-05-2013, 12:43 AM
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
More... (http://www.news-medical.net/news/20131005/New-biomarker-for-pancreatic-cancer-effectively-targets-potential-therapy-for-small-survival-rate.aspx)
More... (http://www.news-medical.net/news/20131005/New-biomarker-for-pancreatic-cancer-effectively-targets-potential-therapy-for-small-survival-rate.aspx)